References
- Golomb, HM, Catovsky D, Golde, DW. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 1978;89:677–683.
- Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 1983;61:349–352.
- Quesada JR, Reubin J, Manning JT, α-Interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984;310:15–18.
- Golomb HM, Vardiman JW. Hairy cell leukemia. Cancer MedicineIn: Holland J, Frei E, editors. Hamilton, ON: BC Decker; 2003. Ch. 131
- Spiers ASD, Parekh SJ, Beshop MB. Hairy cell leukemia: induction of complete remission with pentostatin. J Clin Oncol 1984;2:1336–1342.
- Grever M, Kopecky K, Foucar MK, Randomized comparsion of pentostatin versus interferon α- 2a in previously untreated patients with hairy cell leukemia; an intergroup study. J Clin Oncol 1995;13:974–982.
- Piro L, Carrera CJ, Carson DA, Lasting remissions in hairy cell leukemia induced by a single infusion of 2’ chlorodeoxyadenosine. N Engl J Med 1990;322:1117–1121.
- Saven A, Buriani C, Koziol JA, Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918–1926.
- Mhawech-Fauceglia P, Oberholzer M, Aschenafi S, Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during long-term follow-up in patients treated with cladribine for hairy cell leukemia. Arch Pathol Lab Med 2006;130:374–377.
- Sigal DS, Sharpe R, Burian C, Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood 2010;115:1893–1896.
- Ravandi F, Jorgensen JL, O'Brien SM, Eradication of minimal residual disease in hairy cell leukemia. Blood 2006;107:4658–4662.
- Pileri S, Sabattini E, Poggi S, Bone marrow biopsy in hairy cell leukemia (HCL) patients, histological and immunohistological analysis of 46 cases treated with different therapies. Leuk Lymphoma 1994;14(suppl 1):67–71.
- Konwalinka G, Schirmer M, Hilbe W, Minimal residual disease in hairy cell leukemia after treatment with 2'chlorodeoxyadenosine. Blood Cells Mol Dis 1995;21:142–151.
- Spielberger RT, Mick R, Ratain MJ, Interferon treatment for hairy cell leukemia: An update on cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma 1994;14(suppl 1):89–93.
- Kreitman RJ, Wilson WH, Begeron K, Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy resistant hairy cell leukemia. N Engl J Med 2001;345:241–247.
- Kreitman RJ, Wilson WH, Pastan I. Treatment of hairy cell leukemia: A reply. N Engl J Med 2001;345:1500.
- Kreitman RJ, Pastan I. BL22 and lymphoid malignancies. Best Pract Res Clin Haematol 2006;19:685–699.
- Thomas DA, O'Brien S, Bueso-Ramos C, Rituximab in relapsed or refractory hairy cell leukemia. Blood 2003;102:3906–3911.